AptarGroup Inc. is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing, and protection technologies. The company operates across diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care, and home care. Using proprietary design, engineering, materials science, and manufacturing capabilities, Aptar supports customers by enabling safe, functional, and differentiated product and service delivery. Headquartered in Crystal Lake, Illinois, the company employs approximately 14,000 people across 20 countries and has been in operation since the late 1940s, originally manufacturing aerosol valves in the United States.

Aptar generates revenue through the sale of dispensing pumps, closures, aerosol valves, elastomeric primary packaging components, active material science solutions, and digital health solutions. Dispensing pumps are finger-actuated systems used to dispense sprays, liquids, or lotions from non-pressurized containers. Closures include dispensing and non-dispensing solutions that enable product delivery without cap removal. Aerosol valves are used in pressurized containers for continuous spray and metered-dose applications. Elastomeric components serve injectable drug delivery, including vial stoppers and pre-filled syringe parts. Active material science solutions enhance product stability and shelf life through moisture absorption, pathogen reduction, or odor scavenging. Digital health solutions support patient treatment adherence and remote monitoring via connected devices and diagnostic tools. The company serves approximately 5,000 customers, with no single customer or affiliated group accounting for more than 4% of 2025 net sales.

The company operates through the following segments: Pharma, Beauty, and Closures.

• The Pharma segment is the largest, representing approximately 46% of net sales and 43% of total assets in 2025, and accounted for 69% of adjusted EBITDA excluding non-allocated corporate costs. It serves prescription drug, consumer health care, injectables, active material science solutions, and digital health markets. Products include nasal drug delivery spray pumps, metered dose inhaler valves, elastomeric primary packaging components for injectables, and digital health solutions covering therapeutic areas such as pulmonary, oncology, neurology, diabetes, immunology, and rare disease.

• The Beauty segment is the second largest, representing 35% of net sales and 32% of total assets in 2025, and accounted for 18% of adjusted EBITDA excluding non-allocated corporate costs. It sells pumps, airless systems, and valves to the fragrance, color cosmetics, facial skincare, personal care, and home care markets. Key applications include lotion and spray pumps for hand sanitizers, haircare, and skin moisturizers, as well as continuous spray aerosol valves for deodorants, shaving creams, and sun care products. The segment emphasizes sustainability through transitions to all-plastic lotion pumps.

• The Closures segment accounted for 19% of net sales and 15% of total assets in 2025, and contributed 13% of adjusted EBITDA excluding non-allocated corporate costs. It primarily sells dispensing closures and sealing solutions to the food, beverage, personal care, home care, beauty, and other markets. Food applications include sauces, condiments, and infant nutrition; beverage applications include bottled water, sport drinks, and juices; personal care applications cover haircare, body, and facial skin care products. The segment focuses on sustainability through lightweighting, post-consumer recycled resin, and tethered closures.

Aptar holds a strong position within the competitive markets for dispensing and packaging technologies. The company competes with regional and international players across its served industries. Its competitive advantages stem from consistent innovation, product quality, regulatory expertise, geographic diversity, financial strength, reliability, and a broad portfolio of products and services. Manufacturing strengths include precision molding of complex plastic components, formulation and finishing of elastomer and silicone parts, and high-speed assembly capabilities. While facing competition from low-cost suppliers in certain regions, Aptar differentiates itself through shorter lead times, higher reactivity, and stronger supply reliability valued by customers.

Aptar serves a diverse customer base across multiple industries. Its customers include pharmaceutical companies, consumer health care brands, fragrance and cosmetics manufacturers, food and beverage producers, and personal care and home care product makers. The company does not disclose specific customer names in the filing, noting that no single customer or group of affiliated customers exceeds 4% of 2025 net sales, indicating a broadly distributed customer concentration.